AbbVie (ABBV) 7-Part Filing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $286.39 -0.12%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
EPS Growth %: +101.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
EPS Growth %: +101.1%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) 7-Part Filing
- https://www.sec.gov/Archives/edgar/data/1551152/000110465926019303/tm266774d3_fwp.htm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China's CXMT To Start Advanced Ai Memory Production Despite Poor Yields, Sources Say - Reuters
- Sands China prices $1 billion in senior notes due 2032 and 2033
- QNB Corp. (QNBC) Reports Q3 Loss of $1.30
Create E-mail Alert Related Categories
General NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
